aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Cadence Neuroscience is focused on developing innovative medical device therapies for neurological disorders such as epilepsy and central pain. Utilizing technology developed at Mayo Clinic, the company aims to enhance seizure control through personalized brain stimulation therapies. Their market focus includes medical practitioners seeking advanced, tailored treatment options for patients with neurological conditions.
Cadence Neuroscience's key achievements include the clinical evaluation of their core technology, which promises to improve current brain stimulation protocols. Their impact lies in providing more effective, individualized treatment solutions, potentially transforming the management of neurological disorders.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Medical Devices
Technology
AI, Machine Learning
Tags
Biotech, Healthtech
Model Types
Hardware, Software
Customer Type(s)
Enterprise
Geographic Exposure
Americas
When was Cadence Neuroscience founded?
Cadence Neuroscience was founded in 2017.
Where is Cadence Neuroscience’s headquarters located?
Cadence Neuroscience’s headquarters is located in Redmond, US.
When was Cadence Neuroscience’s last funding round?
Cadence Neuroscience’s most recent funding round was for $26M (USD) in February 2023.
How many employees does Cadence Neuroscience have?
Cadence Neuroscience has 15 employees as of Feb 5, 2024.
How much has Cadence Neuroscience raised to-date?
As of July 05, 2023, Cadence Neuroscience has raised a total of $41M (USD) since Feb 28, 2023.
Add Comparison
Total Raised to Date
$41M
USD
Last Update Feb 28, 2023
Last Deal Details
$26M
USD
Feb 28, 2023
Series B
Total Employees Over Time
15
As of Feb 2024
Cadence Neuroscience Address
8201 164th Ave NE
suite 330
Redmond,
98052
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts